[ASAP] Tricyclic Carboxamide Derivatives as PRMT5 Inhibitors for Treating Cancer

ACS Medicinal Chemistry LettersDOI: 10.1021/acsmedchemlett.2c00292

Source: ACS Medicinal Chemistry Letters - July 12, 2022 Category: Chemistry Authors: Ram W. Sabnis Source Type: research